Early mobilization and functional outcomes in cystic fibrosis patients after lung transplantation: A single-center retrospective study [0.03%]
早期动员与囊性纤维化受者肺移植术后功能结局的相关性分析：一项单中心回顾性研究
Matthieu Reffienna,Jeremy Roussel,Gabor Kalman et al.
Matthieu Reffienna et al.
Background: Rehabilitation has been shown to enhance patient performance before and after lung transplantation, but limited data exist on its role during the immediate post-transplant phase in critical care units. ...
Epidemiology of interstitial lung diseases in a native Afro-Caribbean population of French West Indies [0.03%]
法属西印度群岛本土非裔加勒比人群间质性肺疾病流行病学研究
Sylvain Neveu,Milène Chaptal,Elodie Rossigneux et al.
Sylvain Neveu et al.
Introduction: Data about interstitial lung diseases (ILDs) epidemiology in the Afro-Caribbean population is lacking. Differences in incidence and prevalence compared to European populations have already been reported. The...
Anti-Mi-2 positive interstitial lung disease (ILD): A progressive disease comparable to other myositis-ILD [0.03%]
抗Mi-2阳性间质性肺疾病（ILD）：一种与其它肌炎相关ILD相当的进展性疾病
Bess M Flashner,Ryosuke Imai,Andrew J Synn et al.
Bess M Flashner et al.
Background: Evaluation for interstitial lung disease (ILD) often involves sending a myositis panel that includes myositis-associated and myositis-specific antibodies (MAA and MSA respectively) such as anti-Mi-2. Little is...
The evolution of management in chronic thromboembolic pulmonary hypertension in a non-surgical / balloon pulmonary angioplasty center [0.03%]
非手术/经皮肺动脉成形术中心慢性血栓栓塞性肺高压管理的演变
Mitja Jevnikar,David Montani,Elie Fadel et al.
Mitja Jevnikar et al.
Severe respiratory syncytial virus infection in older adults - burden, clinical outcomes and implications for care [0.03%]
老年人呼吸道合胞病毒感染的负担、临床结果及其对护理的影响
Daniel Guimarães de Oliveira,Ana Grande,Francisco Belchior et al.
Daniel Guimarães de Oliveira et al.
Background: Respiratory syncytial virus (RSV) infection in adults remains under-researched. Increased testing is revealing an emerging picture of severe outcomes within the most prevalent lower respiratory tract infection...
Outcomes of cannabis smoking in patients with lung cancer: findings from KBP-CPHG-2020 [0.03%]
大麻吸烟者肺癌症患者的预后：KBP-CPHG-2020研究发现
Sébastien Couraud,Olivier Molinier,Marielle Sabatini et al.
Sébastien Couraud et al.
Introduction: Cannabis smoking is suspected to be a risk factor for lung cancer. The KBP-2020-CPHG study is a prospective study that collected data from all patients with newly diagnosed lung cancer in non-academic hospit...
Acute effects of fan therapy on exercise-induced breathlessness in healthy adults and people living with chronic respiratory disease: A systematic review [0.03%]
风扇治疗对健康成人和慢性呼吸系统疾病患者运动性呼吸困难的急性影响：系统综述
Julien Da Purificaçao,Clémence Pierret,Tristan Bonnevie et al.
Julien Da Purificaçao et al.
Background: Exercise-induced breathlessness is a common complaint in the general population and a highly prevalent symptom in adults living with chronic diseases, often acting as an important barrier to engaging in physic...
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review [0.03%]
肺动脉高压批准药物用于慢性阻塞性肺疾病相关性肺高血压：系统文献回顾
Beatrice Le Bon Chami,Fida Charif,Claude Semaan et al.
Beatrice Le Bon Chami et al.
Introduction: Pulmonary hypertension (PH) is commonly associated with chronic obstructive pulmonary disease (COPD), with an estimated prevalence of 39%. PH reduces functional capacity and exercise tolerance, and increases...
Progressive course of anti-nuclear matrix protein-2 (NXP-2) positive-interstitial lung disease [0.03%]
抗核基质蛋白-2（NXP-2）阳性间质性肺病的进展过程
Bess M Flashner,Ryosuke Imai,Andrew J Synn et al.
Bess M Flashner et al.
Background: Evaluating the etiology of interstitial lung disease (ILD) commonly involves ordering a myositis panel containing myositis-specific antibodies (MSAs), including anti-NXP-2. However, little is known about the p...
Cédric Mahiat,Jacques Cadranel,Constance Méteyé et al.
Cédric Mahiat et al.
Background: The optimal management strategy for metastatic or advanced-stage non-small-cell lung cancer (NSCLC) after 2 years of immune checkpoint inhibitor (ICI) remains unclear. ...